Literature DB >> 14645224

Evidence that C promoter-binding factor 1 binding is required for Notch-1-mediated repression of activator protein-1.

Jianlin Chu1, Emery H Bresnick.   

Abstract

Cell fate determination in invertebrate and vertebrate systems is regulated by the Notch signaling pathway. Four mammalian Notch genes, Notch 1-4, encode differentially expressed transmembrane receptors. The canonical Notch pathway involves proteolytic liberation of the Notch-1 intracellular domain (NIC-1), which activates CSL (CBF1, Su(H), and Lag-1)-mediated transactivation. We showed previously that NIC-1 also represses activator protein-1 (AP-1)-mediated transactivation. The N-terminal RAM (RBP-Jkappa associated molecule) domain of NIC-1 was required for both activation and repression. To investigate the mechanism of AP-1 repression, we tested whether distinct sequences within the RAM domain mediate activation versus repression. We analyzed the capacity of RAM domain mutants to bind endogenous CBF1, to activate CSL-mediated transactivation, and to repress AP-1. A mutant lacking 20 amino acids of the RAM domain (Delta1759-1778) resembled the RAM domain deletion mutant in being defective in all activities. Analysis of 14 deletion and alanine substitution mutants revealed a correlation between CBF1 binding, CSL-mediated transactivation, and AP-1 repression. Stably transfected K562 cells could only tolerate very low level expression of wild-type NIC-1 and NIC-1 mutants retaining activation/repression activities. By contrast, transcriptionally compromised NIC-1 mutants accumulated at high levels. These results support a model in which the binding of NIC-1 to CBF1 is required for AP-1 repression and reveal a powerful cell-sensing mechanism that suppresses the levels of transcriptionally competent NIC-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645224     DOI: 10.1074/jbc.M311510200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Glucocorticoid and growth factor synergism requirement for Notch4 chromatin domain activation.

Authors:  Jing Wu; Emery H Bresnick
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

Review 2.  Notch signaling and neuronal death in stroke.

Authors:  Thiruma V Arumugam; Sang-Ha Baik; Priyanka Balaganapathy; Christopher G Sobey; Mark P Mattson; Dong-Gyu Jo
Journal:  Prog Neurobiol       Date:  2018-03-21       Impact factor: 11.685

3.  Molecular determinants of NOTCH4 transcription in vascular endothelium.

Authors:  Jing Wu; Fumiko Iwata; Jeffrey A Grass; Cameron S Osborne; Laura Elnitski; Peter Fraser; Osamu Ohneda; Masayuki Yamamoto; Emery H Bresnick
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  Notch signaling activation induces cell death in MAPKi-resistant melanoma cells.

Authors:  Dareen M Mikheil; Kirthana Prabhakar; Ayyan Arshad; Carlos I Rodriguez; Michael A Newton; Vijayasaradhi Setaluri
Journal:  Pigment Cell Melanoma Res       Date:  2019-02-03       Impact factor: 4.693

5.  Assembly of a Notch transcriptional activation complex requires multimerization.

Authors:  Rodrigo Vasquez-Del Carpio; Fred M Kaplan; Kelly L Weaver; Jeffrey D VanWye; Marie-Clotilde Alves-Guerra; David J Robbins; Anthony J Capobianco
Journal:  Mol Cell Biol       Date:  2011-01-18       Impact factor: 4.272

6.  Identification of a Paralog-Specific Notch1 Intracellular Domain Degron.

Authors:  Matthew R Broadus; Tony W Chen; Leif R Neitzel; Victoria H Ng; Jeanne N Jodoin; Laura A Lee; Adrian Salic; David J Robbins; Anthony J Capobianco; James G Patton; Stacey S Huppert; Ethan Lee
Journal:  Cell Rep       Date:  2016-05-19       Impact factor: 9.423

7.  Sustained Notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis.

Authors:  Xiaoyan Zhu; Jie Zhang; Jessica Tollkuhn; Ryosuke Ohsawa; Emery H Bresnick; François Guillemot; Ryoichiro Kageyama; Michael G Rosenfeld
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

8.  Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence.

Authors:  Jordi Guiu; Dylan J M Bergen; Emma De Pater; Abul B M M K Islam; Verónica Ayllón; Leonor Gama-Norton; Cristina Ruiz-Herguido; Jessica González; Nuria López-Bigas; Pablo Menendez; Elaine Dzierzak; Lluis Espinosa; Anna Bigas
Journal:  J Exp Med       Date:  2014-11-10       Impact factor: 14.307

9.  Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling.

Authors:  Jordi Guiu; Ritsuko Shimizu; Teresa D'Altri; Stuart T Fraser; Jun Hatakeyama; Emery H Bresnick; Ryoichiro Kageyama; Elaine Dzierzak; Masayuki Yamamoto; Lluis Espinosa; Anna Bigas
Journal:  J Exp Med       Date:  2012-12-24       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.